Detection of Five Substitution TPO Mutations in Polycystic Ovary Syndrome and Thyroid Hormones Disturbance Patients

    June 2014 in “ مجلة مركز بحوث التقنيات الاحيائية ”
    Mahdi Saber Al-Deresawi, Ali Fadhel Al Najar, Abdul Hussein Moyet Al-Faisal
    Image of study
    TLDR Five different TPO gene mutations were found in PCOS patients with thyroid hormone issues.
    In 2014, a study was conducted on Polycystic Ovary Syndrome (PCOS) patients, revealing the presence of multiple small peripheral cysts and an increase in ovarian volume. The study found that 20.8% of the PCOS patients had hyperthyroidism. The thyroid stimulating hormone-TSH level was significantly higher (17.34±5.12μIU/ml) in 4 PCOS patients with thyroid hormone disturbances compared to PCOS patients without thyroid disturbances or the healthy control group. Additionally, 7 PCOS patients with thyroid hormone disturbances showed lower levels of triiodothyronine-T3 and thyroxine-T4. Molecular analysis detected five substitution thyroid peroxidase genes -TPO mutations in 5 patients with PCOS and thyroid hormone disturbances. Three of these mutations were found in exon 8 and two in exon 9.
    Discuss this study in the Community →

    Research cited in this study

    3 / 3 results

    Related Community Posts Join

    6 / 12 results

      community C’est terrible - at my wits end

      in Female  443 upvotes 1 year ago
      A 29-year-old woman is experiencing gradual hair thinning since age 15, suspects Androgenic Alopecia, and has tried 5% minoxidil with little success. She has purchased various hair loss treatments including minoxidil, dutasteride, finasteride, and spironolactone, but is cautious about starting them due to potential interactions with her ADHD medication.

      community How does hair loss and recovery work?

      in Chat  12 upvotes 2 months ago
      Hair loss varies due to genetic sensitivity to DHT and other factors. Treatments discussed include finasteride, minoxidil, RU58841, and microneedling.

      community Female, 30, PCOS diagnosis, MPB Norwood 2. Endo refuses to give anything other than Spironolactone. Feel like I’m at my wit’s end here.

      in Female  56 upvotes 1 year ago
      A 30-year-old female with PCOS and male pattern baldness is frustrated with her endocrinologist's recommendation of only Spironolactone and minoxidil, feeling that dutasteride, finasteride, and progesterone would be more effective. Other users suggest various online sources for treatments, warn against self-medicating due to potential risks, and recommend seeking a specialized endocrinologist or considering additional treatments like Inositol, Berberine, and dermaneedling.

      community Why balding gets worse in every generation?

      in Chat  81 upvotes 5 months ago
      Balding seems to worsen with each generation, possibly due to stress, diet, and environmental factors. The user started treatments like Minoxidil and finasteride.

    Similar Research

    5 / 1000+ results
      The Role of Hormones in Hidradenitis Suppurativa: A Systematic Review

      research The Role of Hormones in Hidradenitis Suppurativa: A Systematic Review

      6 citations, December 2022 in “International Journal of Molecular Sciences”
      Hormone imbalance is linked to Hidradenitis Suppurativa, a skin condition, and treatments like anti-androgenic therapy and metformin can help. It's also suggested to check patients for insulin resistance and Polycystic Ovary Syndrome.
      Endocrinology

      research Endocrinology

      April 2023 in “Clinical Chemistry and Laboratory Medicine”
      The document concludes that inflammation markers can be used in diabetes, vitamin D3 affects immune pathways, hyperthyroidism changes hormone levels, androgen levels help diagnose Adrenocortical Carcinoma, erectile dysfunction is linked to diabetes, hypogonadism is common in HIV-infected males, and hormones can be biomarkers for various conditions.
      Gonads

      research Gonads

      November 2013 in “John Wiley & Sons, Ltd eBooks”
      The document concludes that accurate diagnosis of male and female gonadal disorders is crucial for effective treatment and better patient outcomes.